48 related articles for article (PubMed ID: 21958448)
1. Treatment decision-making for advanced non-small cell lung cancer and differences among European countries: 1st AIOT-ETOP meeting.
Gridelli C; Stahel R; Besse B; Ciardiello F; Felip E; Gasparini S; Graziano P; Rossi A; de Marinis F
Lung Cancer; 2011 Dec; 74(3):544-8. PubMed ID: 21958448
[TBL] [Abstract][Full Text] [Related]
2. Recent issues in first-line treatment of advanced non-small-cell lung cancer: Results of an International Expert Panel Meeting of the Italian Association of Thoracic Oncology.
Gridelli C; Ardizzoni A; Douillard JY; Hanna N; Manegold C; Perrone F; Pirker R; Rosell R; Shepherd FA; De Petris L; Di Maio M; de Marinis F
Lung Cancer; 2010 Jun; 68(3):319-31. PubMed ID: 20036027
[TBL] [Abstract][Full Text] [Related]
3. Pattern of care for advanced non-small cell lung cancer in the era of histology-based treatment: a survey of the Italian Association of Thoracic Oncology (AIOT).
Gridelli C; Rossi A; de Marinis F
Lung Cancer; 2010 Mar; 67(3):339-42. PubMed ID: 19481831
[TBL] [Abstract][Full Text] [Related]
4. Resources and management strategies for the use of radiotherapy in the treatment of lung cancer in Central and Eastern European countries: results of an International Atomic Energy Agency (IAEA) survey.
Kepka L; Danilova V; Saghatelyan T; Bajcsay A; Utehina O; Stojanovic S; Yalman D; Demiral A; Bondaruk O; Kuddu M; Jeremic B;
Lung Cancer; 2007 May; 56(2):235-45. PubMed ID: 17267070
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of non-small cell lung cancer: advanced (metastatic) disease. Guidelines of clinical practice made by the European Lung Cancer Working Party].
European Lung Cancer Working Party
Rev Med Brux; 2007; 28(6):495-511. PubMed ID: 18265809
[TBL] [Abstract][Full Text] [Related]
6. Observation of the treatment and outcomes of patients receiving chemotherapy for advanced NSCLC in Europe (ACTION study).
Bischoff HG; van den Borne B; Pimentel FL; Arellano J; Langer F; Leschinger MI; Thatcher N
Curr Med Res Opin; 2010 Jun; 26(6):1461-70. PubMed ID: 20394472
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.
Jiang J; Liang X; Zhou X; Huang R; Chu Z
Lung Cancer; 2007 Sep; 57(3):348-58. PubMed ID: 17485133
[TBL] [Abstract][Full Text] [Related]
8. Chemotherapy given near the end of life by community oncologists for advanced non-small cell lung cancer.
Murillo JR; Koeller J
Oncologist; 2006; 11(10):1095-9. PubMed ID: 17110629
[TBL] [Abstract][Full Text] [Related]
9. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
10. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: more treatment options; more things to consider. Introduction.
Bunn PA; Thatcher N
Oncologist; 2008; 13 Suppl 1():1-4. PubMed ID: 18263768
[TBL] [Abstract][Full Text] [Related]
11. European perspective on the costs and cost-effectiveness of cancer therapies.
Drummond MF; Mason AR
J Clin Oncol; 2007 Jan; 25(2):191-5. PubMed ID: 17210939
[TBL] [Abstract][Full Text] [Related]
12. Access to Novel Drugs for Non-Small Cell Lung Cancer in Central and Southeastern Europe: A Central European Cooperative Oncology Group Analysis.
Cufer T; Ciuleanu TE; Berzinec P; Galffy G; Jakopovic M; Jassem J; Jovanovic D; Mihaylova Z; Ostoros G; Thallinger C; Zemanova M; Zielinski C
Oncologist; 2020 Mar; 25(3):e598-e601. PubMed ID: 32162818
[TBL] [Abstract][Full Text] [Related]
13. Lung cancer treatment in New Zealand: physician's attitudes.
Christmas T; Findlay M
N Z Med J; 2004 Jun; 117(1196):U931. PubMed ID: 15280935
[TBL] [Abstract][Full Text] [Related]
14. Direct costs associated with the disease management of patients with unresectable advanced non-small-cell lung cancer in The Netherlands.
Pompen M; Gok M; Novák A; van Wuijtswinkel R; Biesma B; Schramel F; Stigt J; Smit H; Postmus P
Lung Cancer; 2009 Apr; 64(1):110-6. PubMed ID: 18805601
[TBL] [Abstract][Full Text] [Related]
15. Management of stages I and II non-small-cell lung cancer in a New Zealand study: divergence from international practice and recommendations.
Stevens W; Stevens G; Kolbe J; Cox B
Intern Med J; 2008 Oct; 38(10):758-68. PubMed ID: 18298555
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
17. Non-Small Cell Lung Cancer in Countries of Central and Southeastern Europe: Diagnostic Procedures and Treatment Reimbursement Surveyed by the Central European Cooperative Oncology Group.
Ryska A; Buiga R; Fakirova A; Kern I; Olszewski W; Plank L; Seiwerth S; Toth E; Zivka E; Thallinger C; Zielinski C; Brcic L
Oncologist; 2018 Dec; 23(12):e152-e158. PubMed ID: 30076278
[TBL] [Abstract][Full Text] [Related]
18. Molecular and Genomic Profiling of Lung Cancer in the Era of Precision Medicine: A Position Paper from the Italian Association of Thoracic Oncology (AIOT).
Normanno N; Barberis M; De Marinis F; Gridelli C; On The Behalf Of The Aiot Expert Panel
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32575424
[TBL] [Abstract][Full Text] [Related]
19. Targeted combination therapies in oncology: Challenging regulatory frameworks designed for monotherapies in Europe.
Vancoppenolle JM; Koole SN; O'Mahony JF; Franzen N; Burgers JA; Retèl VP; van Harten WH
Drug Discov Today; 2023 Aug; 28(8):103620. PubMed ID: 37201780
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer biomarker testing: perspective from Europe.
Thunnissen E; Weynand B; Udovicic-Gagula D; Brcic L; Szolkowska M; Hofman P; Smojver-Ježek S; Anttila S; Calabrese F; Kern I; Skov B; Perner S; Dale VG; Eri Z; Haragan A; Leonte D; Carvallo L; Prince SS; Nicholson S; Sansano I; Ryska A
Transl Lung Cancer Res; 2020 Jun; 9(3):887-897. PubMed ID: 32676354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
